132 results on '"Hirshaut, Yashar"'
Search Results
2. Evidence for Fetal Antigen in Human Sarcoma
3. Modification of HAT Medium and Hybridoma Formation
4. Enhancement of Hybridoma Formation
5. Retroviruses and Hybridoma Formation : Bystanders or Active Participants?
6. Current Methodologies in Hybridoma Formation
7. Sarcoidosis
8. Case Studies in Bioethics: Choosing a Therapy When Doctors Disagree
9. Gflip/ox in the treatment of advanced pancreatic cancer.
10. Infectious Mononucleosis Followed by Burkittʼs Tumor
11. The Circulating Lymphocyte—Its Role in Infectious Mononucleosis
12. Purification and analysis of a human sarcoma associated antigen
13. Introduction
14. Introductory Comments
15. Introduction
16. Harnessing T-lymphocytes for human cancer immunotherapy.
17. The interaction of Kaposi's sarcoma with monoclonal antibodies to human sarcoma and connective tissue differentiation antigens.
18. Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
19. Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum.
20. A High-Affinity Monoclonal Antibody (GIF-1) to Human Gamma-interferon: Neutralization of Interferon Mediated Inhibition of Retrovirus Production and 2'-5' (A) Synthetase Induction.
21. Effect of short-term levamisole therapy on delayed hypersensitivity.
22. Intralesional injection of the methanol extraction residue of bacillus calmette-guerin (MER) into cutaneous metastases of malignant melanoma.
23. Growing human sarcomas in culture.
24. The search for a viral agent in Hodgkin's disease.
25. INFLUENCE OF POLY(A)·POLY(U) ON IMMUNE RESPONSE IN CANCER PATIENTS.
26. RANDOMIZED TRIAL OF BACILLUS CALMETTE-GUÉRIN (PERCUTANEOUS ADMINISTRATION) AS SURGICAL ADJUVANT IMMUNOTHERAPY FOR PATIENTS WITH STAGE-II MELANOMA.
27. DESIGN OF PHASE-I TRIALS OF IMMUNOPOTENTIATORS FOR CANCER THERAPY: LEVAMISOLE AND CORYNEBACTERIUM PARVUM.
28. Potentiation of vincristine cytotoxicity by hormones: Corticosteroids, androgens, estrogens and progestins.
29. Two dimensional view of combination chemotherapy in vitro.
30. Epstein-barr virus antibody levels in systemic lupus erythematosus.
31. Seroepidemiology of Human Sarcoma Antigen (S1)
32. Infectious Mononucleosis: In Vitro Evidence for Limited Lymphoproliferation
33. Sarcoidosis, Another Disease Associated with Serologic Evidence for Herpes-like Virus Infection
34. HUMAN SARCOMAS IN CULTURE
35. Complement-Fixing Antigen of Human Sarcomas2
36. Enhancement of Hybridoma Formation by Addition of Insulin to HAT Medium (HIAT)
37. A phase I clinical study of a serological test for detection of leukemia-associated antigens (LAA)
38. E.B. VIRUS AND BURKITT'S LYMPHOMA
39. A High-Affinity Monoclonal Antibody (GIF-1) to Human Gamma-interferon: Neutralization of Interferon Mediated Inhibition of Retrovirus Production and 2’-5’ (A) Synthetase Induction
40. Surgical adjuvant therapy of malignant melanoma withCorynebacterium parvum
41. In Memoriam
42. Corynebacterium parvum toxicity in patients with limited and advanced malignancy
43. An enzyme-linked immunosorbert assay (ELISA) for the detection of monoclonal antibodies recognizing surface antigens expressed on viable cells
44. Time to Speak Out
45. Why the Budget Crunch?
46. Variation in expression of S3 antigen in human sarcoma cell lines: Influence of passages and medium on generation of S3
47. Acknowledgements -1988
48. Welcome!
49. Presence of EBV Antibodies in Sera from Wild Chimpanzees
50. VIRUSES AND SYSTEMIC LUPUS ERYTHEMATOSUS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.